223 related articles for article (PubMed ID: 19877370)
1. Schedule of controlled substances; placement of fospropofol into schedule IV. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2009 Oct; 74(192):51234-6. PubMed ID: 19877370
[TBL] [Abstract][Full Text] [Related]
2. Schedules of controlled substances: placement of Zopiclone into schedule IV. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2005 Apr; 70(63):16935-7. PubMed ID: 15806735
[TBL] [Abstract][Full Text] [Related]
3. Schedule of controlled substances: placement of dichloralphenazone into Schedule IV. Final rule.
Drug Enforcement Administration (DEA), Department of Justice
Fed Regist; 2001 Aug; 66(159):42943-4. PubMed ID: 11794309
[TBL] [Abstract][Full Text] [Related]
4. Schedules of controlled substances: placement of tapentadol into schedule II. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2009 May; 74(97):23790-3. PubMed ID: 19507329
[TBL] [Abstract][Full Text] [Related]
5. Schedules of controlled substances: placement of 5-methoxy-N,N-dimethyltryptamine into Schedule I of the Controlled Substances Act. Final rule.
Drug Enforcement Administration (DEA), Department of Justice
Fed Regist; 2010 Dec; 75(243):79296-300. PubMed ID: 21171485
[TBL] [Abstract][Full Text] [Related]
6. Schedules of controlled substances: placement of lisdexamfetamine into schedule II. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2007 May; 72(85):24532-4. PubMed ID: 17520775
[TBL] [Abstract][Full Text] [Related]
7. Schedules of controlled substances: placement of ezogabine into Schedule V. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2011 Dec; 76(241):77895-99. PubMed ID: 22175093
[TBL] [Abstract][Full Text] [Related]
8. Schedules of controlled substances: placement of pregabalin into schedule V. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2005 Jul; 70(144):43633-5. PubMed ID: 16050051
[TBL] [Abstract][Full Text] [Related]
9. Schedules of controlled substances: placement of suvorexant into Schedule IV. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2014 Aug; 79(167):51243-7. PubMed ID: 25167596
[TBL] [Abstract][Full Text] [Related]
10. Schedules of controlled substances: placement of lacosamide into schedule V. Final rule.
Drug Enforcement Administration (DEA), Department of Justice
Fed Regist; 2009 May; 74(97):23789-90. PubMed ID: 19507328
[TBL] [Abstract][Full Text] [Related]
11. Schedules of controlled substances: placement of perampanel into Schedule III. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2013 Dec; 78(231):72013-6. PubMed ID: 24294637
[TBL] [Abstract][Full Text] [Related]
12. Schedule of controlled substances: placement of tramadol into schedule IV. Final rule.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2014 Jul; 79(127):37623-30. PubMed ID: 25016619
[TBL] [Abstract][Full Text] [Related]
13. Schedules of controlled substances: rescheduling of the Food and Drug Administration approved product containing synthetic dronabinol [(-) - [DELTA] less than 9 greater than - (trans)-tetrahydrocannabinol] in sesame oil and encapsulated in soft gelatin capsules from schedule II to schedule III. Department of Justice (DOJ), Drug Enforcement Administration (DEA). Final rule.
Fed Regist; 1999 Jul; 64(127):35928-30. PubMed ID: 10558581
[TBL] [Abstract][Full Text] [Related]
14. Schedules of controlled substances; placement of 2,5-dimethoxy-4-(n)-propylthiophenethylamine and N-benzylpiperazine into Schedule I of the Controlled Substances Act. Final rule.
Drug Enforcement Administration (DEA), Department of Justice
Fed Regist; 2004 Mar; 69(53):12794-7. PubMed ID: 15029891
[TBL] [Abstract][Full Text] [Related]
15. Schedules of controlled substances: temporary placement of three synthetic cannabinoids into Schedule I. Final order.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2013 May; 78(95):28735-9. PubMed ID: 23678676
[TBL] [Abstract][Full Text] [Related]
16. Schedules of controlled substances: rescheduling of buprenorphine from schedule V to schedule III. Final rule.
Drug Enforcement Administration (DEA), Department of Justice
Fed Regist; 2002 Oct; 67(194):62354-70. PubMed ID: 12369590
[TBL] [Abstract][Full Text] [Related]
17. Schedules of controlled substances: placement of alpha-methyltryptamine and 5-methoxy-N,N-diisopropyltryptamine into schedule I of the Controlled Substances Act. Final rule.
Drug Enforcement Administration (DEA), Department of Justice
Fed Regist; 2004 Sep; 69(188):58950-3. PubMed ID: 15455477
[TBL] [Abstract][Full Text] [Related]
18. Schedules of controlled substances: temporary placement of three synthetic cathinones in Schedule I. Final Order.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2011 Oct; 76(204):65371-5. PubMed ID: 22016903
[TBL] [Abstract][Full Text] [Related]
19. Schedules of controlled substances: temporary placement of alpha-methyltryptamine and 5-methoxy-N,N-diisopropyltryptamine into Schedule I. Final rule.
Drug Enforcement Administration (DEA), Department of Justice
Fed Regist; 2003 Apr; 68(65):16427-30. PubMed ID: 12678045
[TBL] [Abstract][Full Text] [Related]
20. Schedules of controlled substances: temporary placement of four synthetic cannabinoids into Schedule I. Final order.
Drug Enforcement Administration, Department of Justice
Fed Regist; 2014 Feb; 79(27):7577-82. PubMed ID: 24605391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]